vascuCAP vs prolaio eVO2peak Module
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent competitors within cardiology AI, offering distinct functionalities. vascuCAP is designed for detailed plaque quantification and cardiovascular risk assessment using CT angiography, ideal for optimizing treatment decisions based on arterial pathology. In contrast, prolaio eVO2peak Module estimates peak oxygen consumption from wearable sensor data, serving as an adjunctive aid for functional cardiovascular evaluation and research.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP (now ElucidVivo/PlaqueIQ) requires non-invasive CT angiography data for its analysis. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
vascuCAP quantifies plaque composition, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, along with 3D visualization and risk stratification for stroke and heart attack. The prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) as an adjunctive aid in clinical evaluation.
vascuCAP is primarily designed for Cardiology, Radiology, and Vascular Surgery. The prolaio eVO2peak Module is relevant for Cardiology, Physical Medicine & Rehab, and Sports Medicine.
vascuCAP focuses on non-invasive CT angiography analysis to quantify plaque composition and assess cardiovascular risk to optimize treatment decisions. The prolaio eVO2peak Module aims to estimate peak oxygen consumption using real-world patient data for cardiovascular research and care, providing information as an adjunctive aid.
vascuCAP utilizes AI-enabled software for CT angiogram analysis, providing histologically-validated plaque quantification and characterization. The prolaio eVO2peak Module applies a locked deep-learning model to process demographic data, single-lead ECG, and triaxial accelerometry inputs from wearable sensors to estimate eVO2peak.